High (18)F-fluorodeoxyglucose uptake in cardiac tumor: A case report

BACKGROUND: Cardiac tumors, especially malignant, are rare but aggressive tumors that mostly arise from the mesenchymal cells and represent a challenging diagnosis for clinicians. Recently, fluorine-18-fluorodiography positron emission tomography and computed tomography ((18)F-FDG PET/CT) is an incr...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying, Pang, Hua, Xu, Lu, Liu, Qiong, Li, Wenbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
6800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591084/
https://www.ncbi.nlm.nih.gov/pubmed/27858836
http://dx.doi.org/10.1097/MD.0000000000004211
Descripción
Sumario:BACKGROUND: Cardiac tumors, especially malignant, are rare but aggressive tumors that mostly arise from the mesenchymal cells and represent a challenging diagnosis for clinicians. Recently, fluorine-18-fluorodiography positron emission tomography and computed tomography ((18)F-FDG PET/CT) is an increasingly popular new technique with diagnosis of tumor. METHODS: We report a case of a right heart tumor showing intense uptake of (18)F-fluorodeoxyglucose ((18)F-FDG) on position emission tomography/computed tomography (PET/CT) imaging. We discuss the clinical course and diagnostic evaluations. RESULTS: The maximal standardized uptake values (SUV(max)) for the cardiac and metastatic lesion were 17.2 and 12.9, respectively. CONCLUSION: (18)F-FDG PET/CT imaging, which enables both morphological characterization and visualization of tumor metabolism, may be an effective and feasible noninvasive method for the diagnosis of malignant cardiac tumors.

Ejemplares similares